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Purpose: Accurate and efficient dose calculation is an important prerequisite to ensure the success 
of radiation therapy. However, all the dose calculation algorithms commonly used in current 
clinical practice have to compromise between calculation accuracy and efficiency, which may 
result in unsatisfactory dose accuracy or highly intensive computation time in many clinical 
situations.  The purpose of this work is to develop a novel dose calculation algorithm based on the 
deep learning method for radiation therapy. 
Methods: In this study we performed a feasibility investigation on implementing a fast and 
accurate dose calculation based on a deep learning technique. A two dimensional (2D) fluence 
map was first converted into a three dimensional (3D) volume using ray traversal algorithm. A 3D 
U-Net like deep residual network was then established to learn a mapping between this converted 
3D volume, CT and 3D dose distribution. Therefore an indirect relationship was built between a 
fluence map and its corresponding 3D dose distribution without using significantly complex neural 
networks. 200 patients, including nasopharyngeal, lung, rectum and breast cancer cases, were 
collected and applied to train the proposed network. Additional 47 patients were randomly selected 
to evaluate the accuracy of the proposed method through comparing dose distributions, dose 
volume histograms (DVH) and clinical indices with the results from a treatment planning system 
(TPS), which was used as the ground truth in this study.   
Results: The proposed deep learning based dose calculation algorithm achieved good predictive 
performance. For 47 tested patients, the average per-voxel bias of the deep learning calculated 
value and standard deviation (normalized to the prescription), relative to the TPS calculation, is 
0.17%±2.28%. The average deep learning calculated values and standard deviations for relevant 
clinical indices were compared with the TPS calculated results and the t-test p-values demonstrated 
the consistency between them.   
Conclusions: In this study we developed a new deep learning based dose calculation method. This 
approach was evaluated by the clinical cases with different sites. Our results demonstrated its 
feasibility and reliability and indicated its great potential to improve the efficiency and accuracy 
of radiation dose calculation for different treatment modalities. 
 
 
 
1. INTRODUCTION 
In modern radiotherapy many new dose delivery techniques, such as intensity-modulated radiation 
therapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic body radiation therapy 
(SBRT), and stereotactic radiosurgery (SRS) have been widely used in clinical practice [1]. These 
techniques require more accurate dose calculation for the situations with irregular small intensity-
modulated beams in heterogeneous human body. In these new treatment modalities, an inverse 
planning is typically employed to search optimal treatment plans, which is a calculation intensive 
dose optimization process. Therefore, an accurate and efficient dose calculation algorithm is an 
important prerequisite to ensure the success of modern radiation therapy.  
      Although the demand for high performance dose calculation continuously increases in clinical 
practice, accurate and efficient dose calculation in an inhomogeneous medium such as human body 
is a complicated task. To date, the most accurate algorithm for dose calculation is the Monte Carlo 
method [2,3], which uses photon and electron transport physics to calculate the trajectories of 
individual particles and thus the pattern of dose deposition. However, it requires the greatest 
computer processing time due to the summing of the energy deposition of each individual particle 
in building the dose distribution. Apart from the Monte Carlo simulation, all other commonly used 
dose calculation algorithms can be categorized into two groups: (1) correction-based algorithms, 
widely used in conventional radiation therapy, which employ semi-empirical approaches to 
account for tissue heterogeneity and surface curvature based on measured dose distributions in 
water [4,5]. These methods do not perform an accurate dose calculation in patients and are rarely 
used now; (2) model-based algorithms, based on convolution/superposition (C/S) techniques [6-
9], which predict patient dose distributions from primary particle fluence and a dose kernel. It 
achieves the dose calculation accuracy close to the results of Monte Carlo simulation with less 
time. Several variations of the C/S algorithms are implemented in commercial treatment planning 
system (TPS), for example, Pinnacle (Philips, Inc.) used the collapsed cone convolution (CCC) 
method [6], Eclipse TPS (Varian Medical Systems) used the anisotropic analytical algorithm 
(AAA) method [10,11] which is based on the pencil beam convolution (PBC) technique [7].  
      Except the Monte Carlo method, all other methods mentioned above make different degrees of 
approximation and simplification which leads to faster calculation speed with loss of dose 
calculation accuracy, thus unsatisfactory in some clinical situations. Furthermore, conventional 
dose calculation algorithms are limited to CT images because they perform calculations based on 
physics principles relying on electron densities of the medium. With the advent of MR (Magnetic 
Resonance) accelerators [12], a new dose calculation technology needs to be explored to break 
through the above limitation and calculate the dose based on the MR images directly.   
      In this study, we proposed a feasibility study on a new dose calculation algorithm based on the 
deep learning method. A voxel traversal algorithm was applied to convert a two dimensional (2D) 
beam fluence map to a three dimensional (3D) volume. A deep neural network was established to 
correlate this fluence map converted 3D volume (FMCV) with the 3D dose distribution. The 
performance of this dose calculation framework has been evaluated by a comprehensive dataset 
with different disease sites. 
    
2. METHODS AND MATERIALS 
We first generated FMCV, based on the beam angle and isocenter position, from a 2D beam 
fluence map using the voxel traversal algorithm [13]. A 3D residual network (ResNet) [14] based 
framework is trained to correlate the FMCV to the 3D dose distribution. The FMCV associated 
with the patient CT volume are the input data for the network. The output of the network is the 3D 
dose distribution from the given fluence map. We built the relationship between the fluence map 
and the 3D dose distribution, with assistance of the FMCV, using deep learning neural network. 
In other words, we implemented a new deep learning based dose calculation algorithm for 
radiotherapy. A flowchart of this proposed technique is shown in Fig. 1. 
 
Fig 1. The flowchart of this study. 
2.A. Patient database 
The database consisted of fluence maps and CT images from 267 IMRT treated patients with 
different disease sites, including nasopharyngeal, lung, rectum and breast cancer cases. These data 
were further randomly divided into three subsets, including 200 training sets, 20 validation sets 
and 47 testing sets. With average 10 beams for each patient, the network uses each individual beam 
as the input and has ~2000 training samples extracted from Pinnacle3 (Philips Radiation Oncology 
Systems, Fitchburg, WI, USA) TPS and preprocessed by our in-house DICOM processing program. 
The original TPS calculated dose, CT images and FMCV for all patients were resampled to a voxel 
resolution of 5 × 5 × 5 mm3 to adapt to a limited GPU memory of 12 GB. 
 
2.B. Fluence map converted 3D volume  
It is noted that establishing the direct relationship between the 2D fluence map with the 3D dose 
distribution, using neural network, is considerably difficult since the input and output of the 
network have different dimensions. An in‐house developed algorithm based on the voxel traversal 
method was implemented to convert a 2D fluence map into a 3D volume. A widely used ray 
traversal algorithm is the three-dimensional digital differential analyzer (3D-DDA) algorithm [13]. 
As an efficient voxel space traversal method, it has been adopted by a number of clinical dose 
calculation software packages. In this study, we used 3D-DDA algorithm to iterate through the 
voxels along the path, in beam’s eye view, connecting the ray source point and each point on the 
fluence map. For each penetrated voxel, a number, which is the pixel value of the connected point 
on the fluence map divided by the squared distance from the ray source to this penetrated voxel, 
was assigned as its voxel value. We emphasize that the proposed FMCV is rather a simple 
technique to convert 2D fluence map into 3D volume. And our results indicate that other dose 
calculation related features, including tissue inhomogeneity, attenuation and dose deposition in the 
patient anatomy can be learned from network training. Fig. 2 illustrates fluence maps, with 
different beam angles 120 and 240, and their corresponding one slice image through the isocenter 
of FMCV volumes. 
 Fig. 2. Two fluence maps (a, c), with beam angles 120 and 240, and their corresponding one slice 
image through the isocenter of FMCV volumes (b, d). 
 
 2.C. Model architecture 
The architecture of the deep learning model is illustrated in Fig. 3. Our group has previously used 
a similar architecture to generate dose distribution prediction for a given patient anatomy [15]. In 
this study, concerning the calculation errors due to the absence of enough superior and inferior CT 
information, we developed a 3D model constructed by 3D convolutional layers to replace the 
published 2D model.  
      As can be seen in Fig. 3, the 3D CT volume and FMCV were treated as different input channel 
in this model. The output dose distribution can be obtained by first downsampling the input data 
followed by the upsampling associated with the long skip connections. The skip connection was 
applied to combat the gradient vanishing and gave us the ability to train deeper networks [14-16]. 
The downsampling and upsampling parts consisted of different combination of stacked building 
blocks of Identity block, Convolution block and Transposed convolution block (shown in Fig. 3) 
with 1x1 and 3x3 kernels. The downsampling process was achieved by one convolutional layer in 
the Convolution block with stride setting to 2 while the upsampling process was implemented by 
setting the stride to 2 for one transposed convolution layer in the Transposed convolution block. 
To maintain a reasonable GPU memory usage, the maximum number of filters for the 
convolutional layer in the network was set to 512. To prevent overfitting, the dropout technique, 
which is a regularization technique that randomly removes or drops out some neurons by a dropout 
rate between 0 and 1 at each training update, was employed. It helps to reduce codependency 
amongst the neurons and thus prevent the overfitting. Also, the data augmentation technique, 
randomly shifting the 3D CT volume, FMCV and 3D dose distribution in X or Y axis, was 
implemented to further prevent the overfitting.  
      ReLU activation function was applied right after each convolution and transposed convolution 
layer [17]. The Adam optimization was used to minimize the mean squared error (MSE) loss 
function with a mini‐batch size of 2. The learning rate was set to 0.0001, and about 200 training 
epochs were taken until the validation loss did not significantly decrease during training. We 
implemented this predictive model in Keras [18], which is a high-level open‐source deep learning 
library written in Python and capable of running on top of TensorFlow. We initialized the weights 
randomly and trained the network from scratch, which took about 3 weeks of computation time, 
using NVIDIA 2080Ti GPU with 12 GB memory.  
 
 
Fig. 3. The architecture of the proposed deep learning model. 
2.D. Model performance 
To evaluate the model’s performance and stability, 47 cases, including nasopharyngeal, lung, 
rectum and breast cancer patients, were randomly selected as independent testing data. For each 
fluence map, we calculated the corresponding dose distribution by applying the trained model. The 
patient’s entire deep learning model calculated (DL calculated) dose distribution was obtained by 
summing doses from all treatment beams. The DL calculated dose volume histograms (DVH) for 
targets and organs at risk (OARs), and their relative clinical indices were further compared with 
the values computed from TPS.   
 
3. RESULTS 
The proposed deep learning based dose calculation method achieved acceptable performance in 
terms of the dose distribution and DVH comparison. The dose distributions for each beam in 47 
new patients were calculated by applying the trained model and the average calculation time is 
less than several seconds. The patients’ overall dose distributions were obtained by summing doses 
from all individual beams in the plan. Fig. 4 and Fig. 5 show the TPS calculated and DL calculated 
dose distributions, as well as pixel-wise dose differences in two axial planes for a nasopharyngeal 
and lung case, respectively. The similar results for breast and rectum patient are shown in the 
Appendix. For all the 47 tested cases, the average per-voxel bias of the DL calculated dose and 
standard deviation (normalized to the prescription) relative to the TPS calculated dose is shown in 
Fig. 6, categorized by disease sites. As we can see, all the average per-voxel bias of the DL 
calculated dose is within 3%. 
      Fig. 7 shows the comparison between the TPS and DL calculated DVHs of OARs and targets 
for a nasopharyngeal, lung, breast and rectum patient. The statistical results of clinical indices for 
OARs and targets, calculating from all the testing nasopharyngeal, lung, breast and rectum patients, 
are reported in Table 1, respectively. The average values and their standard deviations for relevant 
clinical indices were compared and an agreement between the TPS and DL calculated results can 
be seen from Table 1. The t-test p-values, which further test the consistency of the TPS and DL 
calculated results from the statistical point of view, in the last column of Table 1 also verify the 
accuracy of the DL calculated results.  
  
Fig. 4. Dose distributions comparison in two axial planes for a nasopharyngeal patient: TPS 
calculated (left), DL calculated (middle) and pixel-wise differences (right). 
 
Fig. 5. Dose distributions comparison in two axial planes for a lung patient: TPS calculated (left), 
DL calculated (middle) and pixel-wise differences (right). 
 Fig. 6. The average per-voxel bias of the DL calculated dose and standard deviation (normalized 
to the prescription) relative to the TPS calculated dose for all 47 test cases categorized by disease 
site: nasopharyngeal (a), lung (b), breast (c) and rectum (d). 
 
Fig. 7. Comparison between the TPS calculated (solid line) and DL calculated (dashed line) OARs 
and target DHVs for different disease sites: nasopharyngeal (a), lung (b), breast (c) and rectum (d). 
Table 1. The average value and standard deviation (mean ± SD) of relevant clinical indices for all 
the testing patients. 
Structure 
Clinical indices  
(Gy) 
TPS calculation DL calculation 
t-test 
 p-value 
Nasopharyngeal 
Brainstem Dmax 53.45 ± 1.85 55.50 ± 2.12 0.05 
Left parotid  
gland 
Dmean 41.76 ± 3.21 42.56 ± 3.01 0.59 
V30 (%) 68.42 ± 7.48 71.70 ± 7.06 0.35 
Right parotid  
gland 
Dmean 38.07 ± 3.73 38.18 ± 3.38 0.95 
V30 (%) 60.67 ± 10.51 62.20 ± 8.94 0.74 
Spincal cord Dmax 40.55 ± 1.80 42.45 ± 2.27 0.06 
Left len Dmax 6.60 ± 1.26 7.30 ± 1.14 0.23 
Right len Dmax 6.50 ± 0.87 7.00 ± 0.89 0.24 
Left nerve Dmax 52.95 ± 7.19 52.55 ± 7.72 0.91 
Right nerve Dmax 56.65 ± 8.65 52.45 ± 9.11 0.96 
Chiasm Dmax 37.30 ± 18.62 37.45 ± 17.53 0.99 
Left temporal 
lobe 
Dmax 67.85 ± 4.95 67.65 ± 4.67 0.93 
Right temporal 
lobe 
Dmax 67.80 ± 5.01 68.25 ± 5.36 0.86 
Oral cavity Dmean 36.02 ± 4.74 36.55 ± 4.47 0.81 
Larynx Dmean 36.50 ± 3.44 36.41 ± 3.44 0.96 
Lung 
Heart Dmean 11.99 ± 7.71 12.17 ± 7.61 0.96 
Spinal cord Dmax 40.79 ± 2.59 42.71 ± 2.79 0.11 
Breast 
Left lung V20 (%) 7.81 ± 7.65 8.00 ± 7.90 0.97 
Right lung V20 (%) 11.17 ± 10.30 11.32 ± 10.45 0.98 
Heart Dmean 2.44 ± 1.70 2.50 ± 1.69 0.94 
Rectum 
Left femoris V30 (%) 20.65 ± 12.39 21.40 ± 13.77 0.89 
Right femoris V30 (%) 17.11 ± 11.51 17.47 ± 11.92 0.94 
Bladder V30 (%) 64.56 ± 23.26 66.40 ± 23.79 0.85 
 
 
4. DISCUSSION 
Deep learning is widely used for achievable dose prediction and OARs or targets segmentation in 
radiation therapy research [15, 19-24]. Recently, Dong and Xing pioneered the use of deep neural 
network for dose calculation [22, 25]. Thereafter, there are few relevant studies on the introduction 
of deep learning for dose calculation [26-28]. In contrast to previously published studies, in this 
work we proposed a new simple technique to convert 2D fluence map into 3D volume that can be 
used to build the dose calculation deep learning model. The model performance was evaluated in 
a more comprehensive dataset, including four different disease sites and multiple beam angles. As 
can be seen in Fig. 4-7 and Table 1, our preliminary results show that the proposed method is a 
promising new technique for dose calculation and the results are within clinical acceptable limit.  
      One of the key technologies in this study is the implementation of the FMCV, instead of 2D 
fluence map, as the model input. This avoids the adoption of a more complex neural network and 
makes the model training much easier. We know that the 3D dose depends on the isocenter position 
for a given fluence map. As stated in Section 2.B, the path connecting the source point and the 
point on the fluence map is affected by the geometry position of the fluence map. The generation 
procedure of the FMCV takes naturally the isocenter position into account and different isocenter 
position yields different FMCV even if the fluence map is the same. We emphasize that the inverse 
square law is considered in the FMCV generation process, other dose calculation related features, 
such as tissue inhomogeneity, attenuation and dose deposition in the patient anatomy can be 
learned from network training.  
      Our results demonstrate that the proposed model has high dose calculation accuracy with great 
efficiency. For 47 tested patients, the average per-voxel bias of the DL calculated dose and 
standard deviation (normalized to the prescription) is 0.17% ± 2.28% relative to the TPS calculated 
results. As noted in Fig. 4-5, the dose differences become slightly larger in the boundary region. 
This is on account of large variation of material density in the boundary region, which leads to the 
higher uncertainty and inconsistent clinical delivered dose calculation results using the CCC 
algorithm in Pinnacle3 system. In this study we used the 3D doses calculated with the commercial 
TPS dose algorithm (CCC algorithm in Pinnacle) as input to train the model and also used as the 
benchmarks to evaluate the dose accuracy for our proposed mothed. This is acceptable to study 
the feasibility of our proposed method. However, in order to obtain more consistency with actually 
irradiated dose in patients and implement the proposed technique in clinical use, it is better to use 
the dose distributions calculated with more accurate dose algorithms, such as Monte Carlo 
algorithm, as the input to train the model. In this way, we believe that the proposed method is able 
to provide dose calculation accuracy similar to the Monte Carlo simulation with higher efficiency. 
In addition, although the dose calculation for photon beams was tested in this study, the proposed 
method is general enough and can be easily applied to calculate dose distributions for other 
particles, such as proton and electron beams. 
      The proposed method is capable of calculating the dose distribution given the CT and fluence 
map. In the model, the relationship between input and output dose distribution, at the pixel level, 
is established. In this context, we can establish a model applicable to other images besides CT 
images, such as MR images. Therefore, the proposed deep learning-based dose calculation method 
can take the MR images as the input and train a model dedicated to perform dose calculation on 
MR images. This new dose calculation algorithm has great potential to improve dose calculation 
accuracy and efficiency of the MR image-based dose calculation and facilitate the clinical 
procedure for the MR accelerator-based treatment.  
 
5. CONCLUSION 
In this study we developed a new deep learning based method to perform accurate and efficient 
dose calculation. This approach was evaluated by the clinical cases with different sites. Our results 
demonstrated its feasibility and reliability and indicated its great potential to improve the efficiency 
and accuracy of radiation dose calculation for different treatment modalities. 
  
ACKNOWLEDGEMENTS 
This work was partially supported by NIH (R01CA227713 and R01CA223667) and a Google 
Faculty Research Award (LX) and National Natural Science Foundation of China (No. 11805039) 
(JF). 
 
DISCLOSURE of CONFLICTS of INTEREST 
None 
 
 
 
 
 
REFERENCE 
1. Zhang PP, Ellen Yorke, Hu YC. Predictive Treatment Management: Incorporating a Predictive 
Tumor Response Model Into Robust Prospective Treatment Planning for Non-Small Cell Lung 
Cancer. Int J Radiat Oncol Biol Phys. 2014;88:R446-R452. 
2. Metcalfe P, Kron T, Hoban P. The physics of radiotherapy x-rays and electrons. Med Phys. 2007. 
3. Rogers DW. Fifty years of monte carlo simulations for medical physics. Phys Med Biol. 
2006;51:R287-R301. 
4. Milan J, Bentley RE. The storage and manipulation of radiation dose data in a small digital 
computer. Br J Radiol. 1974;47:R115-R121. 
5. Sontag MR, Cunningham JR. The equivalent tissue-air ratio method for making absorbed dose 
calculations in a heterogeneous medium. Radiology. 1978;129:R787-R794. 
6. Boyer A, Mok E. A photon dose distribution model employing convolution calculations. Med 
Phys. 1985;12:R169-R177. 
7. Mohan R, Chui C, Lidofsky L. Differential pencil beam dose computation model for photons. 
Med Phys. 1986;13:R64-R73. 
8. Ahnesjo A. Collapsed cone convolution of radiant energy for photon dose calculation in 
heterogeneous media. Med Phys. 1989;16:R577-R592. 
9. Fogliata A, Nicolini G, Vanetti E, Clivio A, Cozzi L. Dosimetric validation of the anisotropic 
analytical algorithm for photon dose calculation: fundamental characterization in water. Phys Med 
Biol. 2006;51:R1421-R1438. 
10. Ulmer W, Pyyry J, Kaissl W. A 3D photon superposition/convolution algorithm and its 
foundation on results of Monte Carlo calculations. Phys Med Biol. 2005;50:R1767-R1790. 
11. Sievinen J, Ulmer W, Kaissl W. AAA photon dose calculation model in Eclipse. Palo Alto 
(CA): Varian Medical Systems; 2005. 
12. Yang L, Shu HK, Yang XF, et al. Magnetic resonance imaging-based pseudo computed 
tomography using anatomic signature and joint dictionary learning. J Med Imaging (Bellingham). 
2018;5:R034001. 
13. Amanatides J, Woo A. A fast voxel traversal algorithm for ray tracing. Eurographics. 
1987;87:R3-R10. 
14. He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. arXiv:1512.03385. 
15. Fan J, Wang J, Chen Z, Hu C, Zhang Z, Hu W. Automatic treatment planning based on three-
dimensional dose distribution predicted from deep learning technique. Med Phys. 2019;46:R370-
R381. 
16. Seo H, Huang C, Bassenne M, Xiao R, Xing L. Modified U-Net (mU-Net) with Incorporation 
of Object-Dependent High Level Features for Improved Liver and Liver-Tumor Segmentation in 
CT Images. IEEE transactions on medical imaging 2019, doi: 10.1109/TMI.2019.2948320. 
17. Abien F. Deep Learning using Rectified Linear Units (ReLU). arXiv:1803.08375. 
18. Chollet F. keras. 2015. 
19. Xing L, Giger ML, Min JK. Artificial Intelligence in Medicine: Technical Basis and Clinical 
Applications. Elsevier St. Louis MO in press 2020. 
20. Shen L, Zhao W, Xing L. Patient-specific reconstruction of volumetric computed tomography 
images from a single projection view via deep learning. Nature Biomedical Engineering 
2019;3:R880-R888. 
21. Ibragimov B, Xing L. Deep learning for segmentation of organs-at-risks in head and neck CT 
images. Med Phys. 2017;44:R547-R57. 
22. Dong P, Xing L. Deep DoseNet: a deep neural network for accurate dosimetric  
transformation between different spatial resolutions and/or different dose calculation algorithms  
for precision radiation therapy. Phys Med Biol. 2019;65:R035010. 
23. Korani M M, Dong P, Xing L. Deep-Learning Based Prediction of Achievable Dose for  
Personalizing Inverse Treatment Planning. Med Phys. 2016;43:R3724. 
24. Ma M, Kavolchuk N, Buyounoski M, Xing L, Yang Y. Incorporating Dosimetric  
Features into the Prediction of 3D VMAT Dose Distributions Using Deep Convolutional Neural  
Network. Phys Med Biol. 2019;64:R125017. 
25. Dong P, Xing L: Deep DoseNet: A Deep Neural Network based Dose Calculation Algorithm, 
oral presentation in 2020 ASTRO Annual Meeting 2020. 
26. Kontaxis C, Bol GH, Lagendijk JJW, Raaymakers BW. DeepDose: Towards a fast dose 
calculation engine for radiation therapy using deep learning. Phys Med Biol. 2020;65:R75-R85. 
27. Xing Y, Nguyen D, Lu W, Yang M, Jiang S. Technical Note: A feasibility study on deep 
learning-based radiotherapy dose calculation. Med Phy. 2020;47:R94-R100. 
28. Nomura Y, Wang J, Shirato H, Shimizu S, Xing L: Fast spot-scanning proton dose calculation 
method using a three-dimensional convolutional neural network. Phys Med Biol. 2020;65: 
conditionally accepted. 
 
Appendix 
 
Fig. 8. Dose distributions comparison in two axial planes for a breast patient: TPS calculated (left), 
DL calculated (middle) and pixel-wise differences (right). 
 
Fig. 9. Dose distributions comparison in two axial planes for a rectum patient: TPS calculated (left), 
DL calculated (middle) and pixel-wise differences (right). 
